Biotech stocks are off to a blistering start in 2014, and RNN is running 2nd. The top-performing biotech and drug stocks year to date, according to S&P CapitalIQ: Intercept Pharma (ICPT) +329%, Rexahn Pharma (RNN)+116%, Neurocine Biosciences (NBIX) +110%, CorMedix (CRMD) +98%, and Cell Therapeutics (CTIC) +91%. With that said, it can be hard to determine which stock is better than the other, and if you want to make it easier try this SMS text message alert service by sending a text message with the word "run" to 25827.
I still believe that RNN is going to be one of the better BioTech stocks for 2014 despite it dropping under a buck last week. I see smooth sailing from here on out and would hold on to shares if you have them.
In the last 7 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.